Evidence of Clinical Activity for Cetuximab Combined with Irinotecan in a Patient with Refractory Anal Canal Squamous-Cell Carcinoma: Report of a Case

Author: Phan Lan   Hoff Paulo  

Publisher: Springer Publishing Company

ISSN: 0012-3706

Source: Diseases of the Colon & Rectum, Vol.50, Iss.3, 2007-03, pp. : 395-398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content